Fund shareholders of Relmada Therapeutics Inc
ISIN US75955J4022 · United States · LEI 549300217EASRZ9JSF81
- Fund shareholders
- 20
- Of which ETFs
- 3 17 other funds
- Value held
- 27.8M $
- Share of capital
- 3.9 % of 106.7M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,180,304 | 15.2M $ | 0.00 % | 2.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 824,977 | 5.7M $ | 0.01 % | 0.77 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 331,844 | 1.5M $ | 0.00 % | 0.31 % | as of Feb 28, 2026 ↗ |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 295,872 | 2.1M $ | 10.17 % | 0.28 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 144,336 | 658.2K $ | 0.00 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 116,051 | 529.2K $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| SIMT Tax-Managed Small/Mid Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 91,078 | 633.9K $ | 0.09 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 53,081 | 399.2K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 45,197 | 206.1K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 38,589 | 268.6K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 32,256 | 224.5K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 22,430 | 168.7K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 6,925 | 52.1K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 5,817 | 40.5K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 3,700 | 25.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 3,334 | 25.1K $ | 0.48 % | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 2,078 | 15.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,236 | 8.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 620 | 4.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 352 | 2.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 10.17 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.48 % | as of Apr 30, 2026 ↗ |
| SIMT Tax-Managed Small/Mid Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 0.09 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 20 | +9 | 4,200,077 | +194.2 % |
| 2026Q1 | 11 | +2 | 1,427,557 | +47.5 % |
| 2025Q4 | 9 | +2 | 967,722 | -4.1 % |
| 2025Q3 | 7 | -6 | 1,009,569 | -47.3 % |
| 2025Q2 | 13 | -5 | 1,916,544 | -22.5 % |
| 2025Q1 | 18 | -6 | 2,473,615 | -1.5 % |
| 2024Q4 | 24 | 0 | 2,512,435 | +3.8 % |
| 2024Q3 | 24 | -2 | 2,420,854 | +5.3 % |
| 2024Q2 | 26 | 0 | 2,298,689 | +9.9 % |
| 2024Q1 | 26 | -4 | 2,091,601 | -2.2 % |
| 2023Q4 | 30 | 2,137,597 |
Institutional managers
100 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11,063,862 | 76.9M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 8,474,571 | 59M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 6,262,114 | 43M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 4,843,380 | 33.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,763,158 | 33.2M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 4,715,864 | 32.8M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 4,481,606 | 31.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,907,265 | 27.2M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 2,947,369 | 20.5M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 2,688,359 | 18.7M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 2,132,053 | 14.8M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,414,621 | 9.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,289,550 | 9M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,011,572 | 7M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 965,000 | 6.7M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 935,000 | 6.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 848,683 | 5.9M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 842,106 | 5.9M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 842,106 | 5.9M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 842,106 | 5.9M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 842,106 | 5.9M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 729,055 | 5.1M $ | as of Mar 31, 2026 |
| Corient Private Wealth LLC | 719,582 | 5M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 712,540 | 5K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 699,039 | 4.9M $ | as of Mar 31, 2026 |
Declared shareholders of Relmada Therapeutics Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. and 6 others | 6.20 % | 6,508,433 | as of Jun 2, 2026 · SCHEDULE 13G |
| Commodore Capital LP and 3 others | 5.10 % | 5,505,527 | as of Apr 27, 2026 · SCHEDULE 13G |
| Adage Capital Management, L.P. and 2 others | 4.54 % | 4,763,158 | as of Mar 31, 2026 · SCHEDULE 13G |
| Millennium Management LLC and 2 others | 4.40 % | 4,567,952 | as of Jun 16, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Relmada Therapeutics Inc". https://titelia.com/en/stocks/relmada-therapeutics-inc-US75955J4022